ACCESSION: MSBNK-SMB_Measured-HSA001P0101009
RECORD_TITLE: Characterized; piperazin-2-one; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 48
COMMENT: RAW_SPEC {'19_posi_2137': {'bp': 216393.0, 'sum': 921305.0}, '18_posi_1865': {'bp': 133888.0, 'sum': 605835.0}, '16_posi_1866': {'bp': 153622.0, 'sum': 723412.0}, '19_posi_1886': {'bp': 195263.0, 'sum': 908732.0}, '19_posi_1799': {'bp': 206564.0, 'sum': 944729.0}, '6_posi_1845': {'bp': 161115.0, 'sum': 635587.0}, '8_posi_1861': {'bp': 167595.0, 'sum': 812499.0}, '15_posi_1906': {'bp': 174507.0, 'sum': 838827.0}, '16_posi_1952': {'bp': 155805.0, 'sum': 742209.0}, '15_posi_1818': {'bp': 170182.0, 'sum': 779543.0}, '14_posi_1945': {'bp': 174835.0, 'sum': 771007.0}, '17_posi_1800': {'bp': 175023.0, 'sum': 768859.0}, '9_posi_1970': {'bp': 161962.0, 'sum': 769429.0}, '13_posi_1907': {'bp': 166648.0, 'sum': 709400.0}, '10_posi_1909': {'bp': 167032.0, 'sum': 721591.0}, '1_posi_1847': {'bp': 171521.0, 'sum': 762321.0}, '2_posi_1886': {'bp': 174296.0, 'sum': 777848.0}, '17_posi_1970': {'bp': 181957.0, 'sum': 781315.0}, '12_posi_1802': {'bp': 190622.0, 'sum': 914979.0}, '6_posi_1759': {'bp': 148653.0, 'sum': 683191.0}, '13_posi_1825': {'bp': 162877.0, 'sum': 761087.0}, '15_posi_1992': {'bp': 163393.0, 'sum': 702153.0}, '10_posi_1822': {'bp': 169602.0, 'sum': 751883.0}, '12_posi_1888': {'bp': 170689.0, 'sum': 811873.0}, '9_posi_1866': {'bp': 171808.0, 'sum': 778398.0}, '8_posi_1948': {'bp': 172259.0, 'sum': 778679.0}, '12_posi_1965': {'bp': 177381.0, 'sum': 803756.0}, '3_posi_1779': {'bp': 179808.0, 'sum': 772834.0}, '11_posi_1824': {'bp': 187662.0, 'sum': 883343.0}, '2_posi_1800': {'bp': 190144.0, 'sum': 799356.0}, '11_posi_1908': {'bp': 156657.0, 'sum': 763812.0}, '4_posi_1762': {'bp': 171726.0, 'sum': 713001.0}, '7_posi_1862': {'bp': 201008.0, 'sum': 832942.0}, '18_posi_1952': {'bp': 165880.0, 'sum': 742182.0}, '3_posi_1862': {'bp': 184534.0, 'sum': 771436.0}, '19_posi_1968': {'bp': 188237.0, 'sum': 812227.0}, '3_posi_1949': {'bp': 201108.0, 'sum': 800030.0}, '14_posi_1862': {'bp': 202607.0, 'sum': 895728.0}, '19_posi_2057': {'bp': 194034.0, 'sum': 859650.0}, '17_posi_1888': {'bp': 182623.0, 'sum': 868217.0}, '5_posi_1865': {'bp': 170626.0, 'sum': 785182.0}, '16_posi_1781': {'bp': 167433.0, 'sum': 770573.0}, '6_posi_1947': {'bp': 163392.0, 'sum': 701022.0}, '5_posi_1950': {'bp': 159605.0, 'sum': 693428.0}, '4_posi_1846': {'bp': 157979.0, 'sum': 723402.0}, '18_posi_2036': {'bp': 188428.0, 'sum': 831058.0}, '5_posi_1698': {'bp': 175275.0, 'sum': 757007.0}, '4_posi_1931': {'bp': 166685.0, 'sum': 724557.0}}
COMMENT: RETENTION_TIME_STDEV 0.168
COMMENT: PRECURSOR_M/Z_RAW 101.071129
COMMENT: PRECURSOR_M/Z_STDEV 0.000028
COMMENT: PRECURSOR_IN_MS1 mz 101.070966; int 231.358; delta(ppm) 1.485059
COMMENT: PROPOSED_CHARGE_STATE +1; mz 102.074206; int 9.443; cor 0.665
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+CH3OH+H; M+ACN+H; mz 110.071292; int 76.641; cor 0.723
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.260; C4H8N2O; [M+H]+; delta(ppm) 0.259835
COMMENT: PROPOSED_MF SevenGoldenRules 0.412; C3H4N2; [M+CH3OH+H]+; delta(ppm) 0.411538
COMMENT: PROPOSED_MF MS-FINDER 3.782; C4H8N2O; [M+H]+; delta(ppm) 0.254040
COMMENT: PROPOSED_MF MS-FINDER 3.139; C3H4N2; [M+CH3OH+H]+; delta(ppm) 0.254040
COMMENT: PROPOSED_MF SIRIUS5_Sirius 22.644; C4H8N2O; [M+H]+; delta(ppm) 0.254040
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H8N2O; [M+H]+; delta(ppm) 0.254040
COMMENT: PROPOSED_MF SIRIUS6_Sirius 32.424; C3H4N2; [M+CH4O+H]+; delta(ppm) 0.254040
COMMENT: PROPOSED_MF SIRIUS6_Sirius 32.424; C4H8N2O; [M+H]+; delta(ppm) 0.254040
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.680; C2H6N5; [M+H]+; delta(ppm) 13.538589
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C3H4N2; [M+CH4O+H]+; delta(ppm) 0.254040
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H8N2O; [M+H]+; delta(ppm) 0.254040
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.300; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+H]+; OC1=NCCCN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.901; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+H]+; C1CNC(=O)CN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.821; IMAGWKUTFZRWSB-HYXAFXHYSA-N; [M+H]+; C\C=N/N(C)C=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.786; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+H]+; O=NN1CCCC1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.966; IMAGWKUTFZRWSB-HYXAFXHYSA-N; [M+H]+; Gyromitrin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.717; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+H]+; N-Nitroso-pyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.694; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+H]+; piperazin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.568; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+H]+; perhydropyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.910; RAXXELZNTBOGNW-UHFFFAOYSA-N; [M+CH3OH+H]+; Imidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.649; WTKZEGDFNFYCGP-UHFFFAOYSA-N; [M+CH3OH+H]+; 1H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.441; DEEPVUMBLJVOEL-UHFFFAOYSA-N; [M+CH3OH+H]+; 3H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.441; LGRQUXHYJBFGTM-UHFFFAOYSA-N; [M+CH3OH+H]+; 4H-imidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.441; NILYRCYRBPDITI-UHFFFAOYSA-N; [M+CH3OH+H]+; 4H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.441; FSMNWWSKEJUTCG-UHFFFAOYSA-N; [M+CH3OH+H]+; 4,5-dihydroimidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.441; QVDCANBBJMFTOO-UHFFFAOYSA-N; [M+CH3OH+H]+; aziridine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.024; ZFFWIOSEDOAZAY-UHFFFAOYSA-N; [M+CH3OH+H]+; UNPD118818
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.691; GFZMFCVDDFHSJK-UHFFFAOYSA-N; [M+CH3OH+H]+; UNPD130652
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+H]+; perhydropyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GFZMFCVDDFHSJK-UHFFFAOYSA-N; [M+CH3OH+H]+; UNPD130652
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.991; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+H]+; piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.756; IMAGWKUTFZRWSB-HYXAFXHYSA-N; [M+H]+; Gyromitrin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.703; DEEPVUMBLJVOEL-UHFFFAOYSA-N; [M+CH3OH+H]+; 3H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.636; LGRQUXHYJBFGTM-UHFFFAOYSA-N; [M+CH3OH+H]+; 4H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.636; FSMNWWSKEJUTCG-UHFFFAOYSA-N; [M+CH3OH+H]+; 4,5-dihydroimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.620; WTKZEGDFNFYCGP-UHFFFAOYSA-N; [M+CH3OH+H]+; 1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.573; RAXXELZNTBOGNW-UHFFFAOYSA-N; [M+CH3OH+H]+; Imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.520; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+H]+; N-Nitroso-pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NILYRCYRBPDITI-UHFFFAOYSA-N; [M+CH3OH+H]+; 4H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZFFWIOSEDOAZAY-UHFFFAOYSA-N; [M+CH3OH+H]+; UNPD118818
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; QVDCANBBJMFTOO-UHFFFAOYSA-N; [M+CH3OH+H]+; aziridine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.573; RAXXELZNTBOGNW-UHFFFAOYSA-N; [M+CH3OH+H]+; 1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.525; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+H]+; 1-nitrosopyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.205; WTKZEGDFNFYCGP-UHFFFAOYSA-N; [M+CH3OH+H]+; 1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.205; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+H]+; piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.004; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+H]+; 1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.660; IMAGWKUTFZRWSB-HWKANZROSA-N; [M+H]+; N-[(E)-ethylideneamino]-N-methylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.621; DWEQVNFWAKJCEY-UHFFFAOYSA-N; [M+H]+; 4-methylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.377; GFZMFCVDDFHSJK-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(methylideneamino)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.204; JTPZTKBRUCILQD-UHFFFAOYSA-N; [M+H]+; 1-methylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.149; JKZWEWZMYSBQME-UHFFFAOYSA-N; [M+H]+; 1-methylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.123; CWTDBXBAFSXFET-UHFFFAOYSA-N; [M+H]+; 3-methylimidazolidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.118; YNDAMDVOGKACTP-UHFFFAOYSA-N; [M+H]+; 3-aminopyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.098; LSROBYZLBGODRN-UHFFFAOYSA-N; [M+H]+; 1-aminopyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; JIMSBKAHGYGPLD-UHFFFAOYSA-N; [M+H]+; 4-aminopyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.057; VPJDULFXCAQHRC-UHFFFAOYSA-N; [M+H]+; prop-2-enylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; WYVJDRGXWOXCCH-UHFFFAOYSA-N; [M+H]+; 5-methylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.925; PGZUFTROELAOMP-UHFFFAOYSA-N; [M+CH3OH+H]+; aziridine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.831; WJYMBVJBSFMDLE-HWKANZROSA-N; [M+H]+; (2E)-2-(dimethylhydrazinylidene)acetaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.826; UAUSQEVPWPGBHG-UHFFFAOYSA-N; [M+H]+; 3-aminobut-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.798; OWSNZTOUPZXKPJ-UHFFFAOYSA-N; [M+H]+; N-methyl-N-prop-2-enylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.766; AFSJSMGLWQBMPX-BYPYZUCNSA-N; [M+H]+; (3S)-4-amino-3-hydroxybutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.744; VALZSZJVEFACEZ-UHFFFAOYSA-N; [M+H]+; azetidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.741; KKCWBKUOPJMUQV-UHFFFAOYSA-N; [M+H]+; azetidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.718; MHFBJJKCSNFJEO-UHFFFAOYSA-N; [M+H]+; 4,5-dihydro-1,2-oxazol-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.708; AWDNCVJVQYZMTL-UHFFFAOYSA-N; [M+H]+; N-methylaziridine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.672; OMCUPXRCMTUDHI-UHFFFAOYSA-N; [M+H]+; N'-hydroxycyclopropanecarboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.672; KAXILSKFDQXZPP-UHFFFAOYSA-N; [M+H]+; N-ethenyl-N-ethylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.662; FSRLLJVJCVKHQI-UHFFFAOYSA-N; [M+H]+; 2-amino-3-hydroxy-2-methylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.656; VPVZSRIIAONGMU-UHFFFAOYSA-N; [M+H]+; 5,6-dihydro-4H-1,3-oxazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.650; ZHFKVNRMZIOKGZ-UHFFFAOYSA-N; [M+H]+; 5-methyl-4,5-dihydro-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.648; GQVNTZNZAGYMPA-UHFFFAOYSA-N; [M+H]+; N-methyl-1,3-oxazolidin-2-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.647; JFGXRDGYMLGBBB-UHFFFAOYSA-N; [M+H]+; 1-aminocyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.642; MOTOCPZCBQSREP-UHFFFAOYSA-N; [M+H]+; N-cyclopropyl-N-methylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.638; CLMGCKCDSPUQEE-UHFFFAOYSA-N; [M+H]+; cyclopropylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.632; JFYKIEHOOZWARC-UHFFFAOYSA-N; [M+H]+; cyclopropanecarbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.630; YXAYZDNOWMFZLL-UHFFFAOYSA-N; [M+H]+; 2-(3-methyldiazirin-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.626; HAVLTQQTLZIBAK-UHFFFAOYSA-N; [M+H]+; 5-methyl-4,5-dihydro-1,2-oxazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.624; PIXPFRMNXPKTFS-UHFFFAOYSA-N; [M+H]+; 4-methyl-4,5-dihydro-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.529; IBYIOHMUWBIKCY-UHFFFAOYSA-N; [M+H]+; N-methoxyazetidin-3-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.496; VUIHTBYGRDVRDE-UHFFFAOYSA-N; [M+H]+; 3-aminooxybutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.482; RPGPPCHMKDWLRT-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methoxypropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -66.613; YNDAMDVOGKACTP; [M+H]+; Ambcb4019954
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -67.332; IWELDVXSEVIIGI; [M+H]+; piperazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -135.312; KKCWBKUOPJMUQV; [M+H]+; 2-azetidinecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.989; NQPJDJVGBDHCAD; [M+H]+; Propyleneurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -149.052; JTPZTKBRUCILQD; [M+H]+; 1-Methyl-2-imidazolidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -149.277; WNYADZVDBIBLJJ; [M+H]+; Nitrosopyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -163.789; DWEQVNFWAKJCEY; [M+H]+; 4-Methyl-2-imidazolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -174.491; WJYMBVJBSFMDLE; [M+H]+; Glyoxal mono-dimethylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.593; UAUSQEVPWPGBHG; [M+H]+; 3-Aminocrotonamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.664; DZOWYKFQSIAYCW; [M+H]+; 3,6-dihydro-2H-oxazin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -194.260; IMAGWKUTFZRWSB; [M+H]+; Ethylidene gyromitrin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.976; VPQRCGYRFWYOEO; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.141; KAXILSKFDQXZPP; [M+H]+; Vinylethylnitrosamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.275; YXAYZDNOWMFZLL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.709; JFYKIEHOOZWARC; [M+H]+; Oprea1_824763
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -214.267; OWSNZTOUPZXKPJ; [M+H]+; Methylallylnitrosamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -216.657; ZJULPBMTEMGRNC; [M+H]+; 2-Methoxyimidazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -224.937; OMCUPXRCMTUDHI; [M+H]+; Cyclopropanecarboxamidoxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.036; AWDNCVJVQYZMTL; [M+H]+; N-Methylethyleneurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -237.120; ZHFKVNRMZIOKGZ; [M+H]+; 2-Oxazolamine, 4,5-dihydro-5-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.390; VPJDULFXCAQHRC; [M+H]+; Allylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.392; CLMGCKCDSPUQEE; [M+H]+; cyclopropylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -258.328; PIXPFRMNXPKTFS; [M+H]+; 4-Methyl-oxazolidin-(2Z)-ylideneamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.346; YNDAMDVOGKACTP; [M+H]+; Ambcb4019954
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -40.861; IWELDVXSEVIIGI; [M+H]+; 1,3,3,4,5,5-Hexadeuteriopiperazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -73.287; CWTDBXBAFSXFET; [M+H]+; 3-Methylimidazolidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -81.990; IMAGWKUTFZRWSB; [M+H]+; Gyromitrin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -90.137; JTPZTKBRUCILQD; [M+H]+; 1-(Methyl-d3)-2-imidazolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -109.443; KAXILSKFDQXZPP; [M+H]+; Vinylethylnitrosamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -112.628; WJYMBVJBSFMDLE; [M+H]+; Glyoxal dimethylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.558; ZJULPBMTEMGRNC; [M+H]+; 3,4,5,5-tetradeuterio-2-methoxy-4H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -116.979; UAUSQEVPWPGBHG; [M+H]+; (Z)-3-aminobut-2-enimidate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.282; VPJDULFXCAQHRC; [M+H]+; Allylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.910; MFCHWYSOGVAXNC; [M+H]+; N-methyl-N-(nitrosomethyl)ethenamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.776; IWELDVXSEVIIGI; [M+H]+; 1,3,3,4,5,5-Hexadeuteriopiperazin-2-one
COMMENT: CONFIDENCE Level 3: Tentative candidate, piperazin-2-one, IWELDVXSEVIIGI-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (3), MetFrag:MsfinderDB (2), MetFrag:PubchemLite (3);
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C4H8N2O
CH$EXACT_MASS: 100.063663
CH$SMILES: C1CNC(=O)CN1
CH$IUPAC: InChI=1S/C4H8N2O/c7-4-3-5-1-2-6-4/h5H,1-3H2,(H,6,7)
CH$NAME: Piperazinone
CH$NAME: piperazin-2-one
CH$LINK: INCHIKEY IWELDVXSEVIIGI-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:231360
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 3.785
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 101.070965
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0h90-9300000000-267962dec50b7c6badba
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0495233 34.6824 56.050155 0.9634 7.63 0.3753 48 f{C3H6N1}/0.85ppm,p-C1H3N1O1
  59.0604671 693.9333 59.061105 0.3048 191.83 0.3232 48 f{C2H7N2}/1.57ppm,p-C2H2O1
  60.0444707 908.6534 60.045110 0.2665 105.49 0.2155 48 f{C2H6N1O1}/1.34ppm,p-C2H3N1
  71.0603068 57.7250 71.060920 1.0695 13.20 0.2121 48 f{C3H7N2}/-0.95ppm,p-C1H2O1
  72.0444035 582.6966 72.045010 0.3192 51.67 0.5692 48 f{C3H6N1O1}/0.18ppm,p-C1H3N1
  73.0760309 973.9534 73.076630 0.2463 76.32 0.7135 48 f{C3H9N2}/0.08ppm,p-C1O1
  83.0604013 75.0904 83.060905 1.2521 13.73 0.3385 48 f{C4H7N2}/0.32ppm,p-H2O1
  84.0443780 23.9861 84.044870 1.3802 5.81 0.3325 43 f{C4H6N1O1}/-0.15ppm,p-H3N1
  101.0346170 38.6632 101.034930 1.6727 13.35 0.1377 44 ?
  101.0710073 999.0000 101.071320 0.2671 56.28 1.0000 48 f{C4H9N2O1}/0.67ppm,p
  101.0788024 90.4599 101.079115 0.7618 13.66 0.2940 48 ?
  101.1074076 48.3651 101.107720 1.0385 13.28 0.2193 48 ?
PK$NUM_PEAK: 12
PK$PEAK: m/z int. rel.int.
  56.049523 34.68 34
  59.060467 693.93 693
  60.044471 908.65 908
  71.060307 57.73 57
  72.044403 582.70 582
  73.076031 973.95 973
  83.060401 75.09 75
  84.044378 23.99 23
  101.034617 38.66 38
  101.071007 999.00 999
  101.078802 90.46 90
  101.107408 48.37 48
//
